Chemical Structure (Atrovent 01)
Atrovent Aerosol, Metered
Product Images NDC 0597-0087
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Atrovent (NDC 0597-0087). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Boehringer Ingelheim Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Atrovent 02)
Figure 1 (Atrovent 03)
Figure 2 (Atrovent 04)
Figure 3 (Atrovent 05)
Figure 4 (Atrovent 06)
Figure 5 (Atrovent 07)
Figure 6 (Atrovent 08)
Figure 7a (Atrovent 09)
Figure 7b (Atrovent 10)
Image (Atrovent 10a)
Principal Display Panel (17 mcg Carton)
Atrovent HFA is an inhalation aerosol medication that delivers 17 mcg of ipratropium bromide per actuation from the mouthpiece. The medication is distributed by Boehringer Ingelheim Pharmaceuticals Inc. and licensed under Boehringer Ingelheim International GmbH. The canister is 12.9 grams and contains 200 metered actuations. The medication must be stored between 20°C to 25°C and should not be exposed to heat over 120°F or below 10°C. It is important to read the instructions for use and avoid spraying in eyes. The product is for oral inhalation with the Atrovent HFA Inhalation Aerosol mouthpiece only.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
